{"id":5990,"date":"2026-01-19T15:01:18","date_gmt":"2026-01-19T15:01:18","guid":{"rendered":"https:\/\/oncopeptides.com\/about\/corporate-governance\/kommitteer\/"},"modified":"2026-03-11T13:59:50","modified_gmt":"2026-03-11T13:59:50","slug":"kommitteer","status":"publish","type":"about-us","link":"https:\/\/oncopeptides.com\/sv\/om-oss\/corporate-governance\/kommitteer\/","title":{"rendered":"Kommitteer"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"5990\" class=\"elementor elementor-5990 elementor-2712\" data-elementor-post-type=\"about-us\">\n\t\t\t\t<style>\n                .elementor-element-ecee6c4{\n                --padding-top: var(--webien-padding-top-none);\n                --padding-right: var(--webien-padding-right-none);\n                --padding-bottom: var(--webien-padding-bottom-none);\n                --padding-left: var(--webien-padding-left-none);\n                }\n            <\/style><div class=\"webien-container-padding-none elementor-element elementor-element-ecee6c4 e-con-full main e-flex e-con e-child\" data-id=\"ecee6c4\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-e85e3dd elementor-widget elementor-widget-heading\" data-id=\"e85e3dd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Styrelsens kommitt\u00e9er<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b84a829 elementor-widget elementor-widget-text-editor\" data-id=\"b84a829\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Styrelsen har inr\u00e4ttat tv\u00e5 kommitt\u00e9er; revisionsutskottet och ers\u00e4ttningsutskottet. Styrelsen har antagit arbetsordningar f\u00f6r var och en av dessa kommitt\u00e9er. <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t<style>\n                .elementor-element-7f69345{\n                --padding-top: var(--webien-padding-top-none);\n                --padding-right: var(--webien-padding-right-none);\n                --padding-bottom: var(--webien-padding-bottom-none);\n                --padding-left: var(--webien-padding-left-none);\n                }\n            <\/style><div class=\"webien-container-padding-none elementor-element elementor-element-7f69345 e-con-full e-flex e-con e-child\" data-id=\"7f69345\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-e5b9164 elementor-widget elementor-widget-heading\" data-id=\"e5b9164\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Revisionsutskott<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d8ed17e elementor-widget elementor-widget-text-editor\" data-id=\"d8ed17e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Revisionsutskottets roll \u00e4r fr\u00e4mst att \u00f6vervaka bolagets finansiella st\u00e4llning, att \u00f6vervaka effektiviteten i bolagets interna kontroll, internrevision och riskhantering, att informeras om revisionen av \u00e5rsredovisningen och koncernredovisningen samt att granska och \u00f6vervaka revisorns opartiskhet och oberoende. Revisionsutskottet ska \u00e4ven bist\u00e5 valberedningen med f\u00f6rslag till beslut om val och ers\u00e4ttning till revisorn. <\/p><p>Revisionsutskottet best\u00e5r av Christine Rankin (ordf\u00f6rande), Per Wold-Olsen och Per Samuelsson.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<style>\n                .elementor-element-6a194d7{\n                --padding-top: var(--webien-padding-top-none);\n                --padding-right: var(--webien-padding-right-none);\n                --padding-bottom: var(--webien-padding-bottom-none);\n                --padding-left: var(--webien-padding-left-none);\n                }\n            <\/style><div class=\"webien-container-padding-none elementor-element elementor-element-6a194d7 e-con-full e-flex e-con e-child\" data-id=\"6a194d7\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-124af94 elementor-widget elementor-widget-heading\" data-id=\"124af94\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Ers\u00e4ttningsutskott<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-431cc47 elementor-widget elementor-widget-text-editor\" data-id=\"431cc47\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Ers\u00e4ttningsutskottets roll \u00e4r fr\u00e4mst att bereda fr\u00e5gor om ers\u00e4ttning och andra anst\u00e4llningsvillkor f\u00f6r verkst\u00e4llande direkt\u00f6ren och \u00f6vriga medlemmar i ledningen. Ers\u00e4ttningsutskottet ska \u00e4ven f\u00f6lja upp och utv\u00e4rdera p\u00e5g\u00e5ende och avslutade program f\u00f6r r\u00f6rlig ers\u00e4ttning till bolagets ledning samt f\u00f6lja upp och utv\u00e4rdera till\u00e4mpningen av de riktlinjer f\u00f6r ers\u00e4ttning till ledande befattningshavare som antagits av \u00e5rsst\u00e4mman. <\/p><p>Ers\u00e4ttningsutskottet best\u00e5r av Per Wold-Olsen (ordf\u00f6rande), Brian Stuglik och Per Samuelsson.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3fbed8d dotted-divider elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"3fbed8d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a430c5b elementor-widget elementor-widget-heading\" data-id=\"a430c5b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Valberedning 2026<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6f206c0 elementor-widget elementor-widget-text-editor\" data-id=\"6f206c0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Enligt principerna f\u00f6r tills\u00e4ttande av valberedningen i Oncopeptides AB (publ) ska valberedningen inf\u00f6r \u00e5rsst\u00e4mman 2026 best\u00e5 av ledam\u00f6ter utsedda av de tre st\u00f6rsta aktie\u00e4garna i fr\u00e5ga om r\u00f6standel per utg\u00e5ngen av tredje kvartalet 2025 som \u00e4r villiga att delta i valberedningen, tillsammans med styrelsens ordf\u00f6rande.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ea292af elementor-widget elementor-widget-text-editor\" data-id=\"ea292af\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Valberedningen inf\u00f6r \u00e5rsst\u00e4mman 2026 best\u00e5r av f\u00f6ljande personer som tillsammans representerar cirka 20 % av antalet aktier och r\u00f6ster i bolaget baserat p\u00e5 aktie\u00e4garinformationen per utg\u00e5ngen av september 2025.<\/p><ul><li>Staffan Lindstrand, utsedd av HealthCap VI L.P.<\/li><li>Jonas Brambeck, utsedd av Jakob Lindberg<\/li><li>Anna Henricsson, utsedd av Handelsbanken Fonder<\/li><li>Per Wold-Olsen, styrelsens ordf\u00f6rande<\/li><\/ul><p>Valberedningens f\u00f6rslag kommer att presenteras i kallelsen till \u00e5rsst\u00e4mman 2026 samt under Bolagsst\u00e4mma 2026 h\u00e4r p\u00e5 webbsidan.<\/p><p>Aktie\u00e4gare som vill l\u00e4mna f\u00f6rslag till valberedningen kan g\u00f6ra detta genom att s\u00e4nda e-post till <a href=\"mailto:info@oncopeptides.com\">info@oncopeptides.com<\/a> (rubrik \u201dValberedning\u201d) eller via brev till:<\/p><p>Oncopeptides AB (publ)<br>Att: Oncopeptides Nomination Committee<br>Luntmakargatan 46<br>SE-111 37 Stockholm, Sweden<\/p><p>Eventuella f\u00f6rslag m\u00e5ste vara valberedningen tillhanda <strong>senast den 1 april 2026<\/strong> f\u00f6r att ing\u00e5 i kallelsen och dagordningen f\u00f6r \u00e5rsst\u00e4mman.<\/p><p> <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-59c60fa dotted-divider elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"59c60fa\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-86658be elementor-widget elementor-widget-heading\" data-id=\"86658be\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Om valberedningen<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d145029 elementor-widget elementor-widget-text-editor\" data-id=\"d145029\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Enligt koden ska bolaget ha en valberedning vars uppgifter ska omfatta beredning och utarbetande av f\u00f6rslag avseende val av styrelseledam\u00f6ter, styrelsens ordf\u00f6rande, st\u00e4mmans ordf\u00f6rande och revisorer. Valberedningen ska \u00e4ven f\u00f6resl\u00e5 arvoden till styrelseledam\u00f6terna och revisorerna. <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6354422 elementor-widget elementor-widget-text-editor\" data-id=\"6354422\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Vid \u00e5rsst\u00e4mman den 17 maj 2018 beslutades att anta principer f\u00f6r valberedningen som ska g\u00e4lla tills vidare. Valberedningen ska best\u00e5 av fyra ledam\u00f6ter som representerar de tre st\u00f6rsta aktie\u00e4garna vid utg\u00e5ngen av tredje kvartalet varje r\u00e4kenskaps\u00e5r, tillsammans med styrelsens ordf\u00f6rande. De st\u00f6rsta aktie\u00e4garna avser de registrerade aktie\u00e4garna eller p\u00e5 annat s\u00e4tt k\u00e4nda aktie\u00e4garna efter utg\u00e5ngen av tredje kvartalet. Innan en ledamot accepterar en inbjudan att ing\u00e5 i valberedningen m\u00e5ste denne noga \u00f6verv\u00e4ga om det f\u00f6religger n\u00e5gon intressekonflikt.   <\/p><p>Valberedningens sammans\u00e4ttning ska offentligg\u00f6ras p\u00e5 bolagets webbplats senast sex m\u00e5nader f\u00f6re \u00e5rsst\u00e4mman. Om en representant avg\u00e5r eller l\u00e4mnar uppdraget innan det \u00e4r slutf\u00f6rt ska den aktie\u00e4gare som utsett den avg\u00e5ende ledamoten utse en ny ledamot. Om en aktie\u00e4gare som har utsett en ledamot i valberedningen v\u00e4sentligt minskar sitt \u00e4gande i bolaget ska n\u00e4sta aktie\u00e4gare i storleksordning, om valberedningen s\u00e5 beslutar, erbjudas att utse en ledamot i valberedningen. N\u00e4r en s\u00e5dan representant har utsetts ska denne vara ledamot i valberedningen och ers\u00e4tta den tidigare ledamoten som inte l\u00e4ngre representerar en av de tre st\u00f6rsta aktie\u00e4garna. Valberedningen ska uppfylla de sammans\u00e4ttningskrav som anges i koden.    <\/p><p>Om de st\u00f6rre aktie\u00e4gare som har r\u00e4tt att utse ledam\u00f6ter till valberedningen \u00f6nskar utse personer som skulle inneb\u00e4ra att sammans\u00e4ttningskraven enligt koden inte uppfylls, ska en st\u00f6rre aktie\u00e4gare ha prioritet f\u00f6r sitt f\u00f6rstahandsval av ledamot framf\u00f6r en mindre aktie\u00e4gare. Vid utn\u00e4mning av en ny ledamot till f\u00f6ljd av v\u00e4sentliga f\u00f6r\u00e4ndringar i \u00e4gandet ska den aktie\u00e4gare som ska utse en ny ledamot, vid utn\u00e4mningen av en ny ledamot, beakta valberedningens befintliga sammans\u00e4ttning. <\/p><p>Valberedningen ska utse en ordf\u00f6rande bland sina ledam\u00f6ter. Styrelsens ordf\u00f6rande eller annan styrelseledamot ska inte vara ordf\u00f6rande i valberedningen. Mandatperioden f\u00f6r den utsedda valberedningen g\u00e4ller till dess att en ny valberedning utses. Arvoden kan utg\u00e5 till ledam\u00f6terna i valberedningen efter beslut av bolagsst\u00e4mman.   <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-cfc22f2 dotted-divider elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"cfc22f2\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-608b797 elementor-widget elementor-widget-spacer\" data-id=\"608b797\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<style>\n                .elementor-element-c44622d{\n                --padding-top: var(--webien-padding-top-none);\n                --padding-right: var(--webien-padding-right-none);\n                --padding-bottom: var(--webien-padding-bottom-none);\n                --padding-left: var(--webien-padding-left-none);\n                }\n            <\/style><div class=\"webien-container-padding-none elementor-element elementor-element-c44622d e-con-full e-flex e-con e-child\" data-id=\"c44622d\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<style>\n                .elementor-element-b7fe16d{\n                --padding-top: var(--webien-padding-top-none);\n                --padding-right: var(--webien-padding-right-none);\n                --padding-bottom: var(--webien-padding-bottom-none);\n                --padding-left: var(--webien-padding-left-none);\n                }\n            <\/style><div class=\"webien-container-padding-none elementor-element elementor-element-b7fe16d e-con-full e-flex e-con e-child\" data-id=\"b7fe16d\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-f255660 elementor-widget elementor-widget-heading\" data-id=\"f255660\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Tidigare valberedningar<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<style>\n                .elementor-element-248991e{\n                --padding-top: var(--webien-padding-top-none);\n                --padding-right: var(--webien-padding-right-none);\n                --padding-bottom: var(--webien-padding-bottom-none);\n                --padding-left: var(--webien-padding-left-none);\n                }\n            <\/style><div class=\"webien-container-padding-none elementor-element elementor-element-248991e e-con-full e-flex e-con e-child\" data-id=\"248991e\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-37e10e0 elementor-widget elementor-widget-jet-listing-grid\" data-id=\"37e10e0\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;columns&quot;:&quot;1&quot;}\" data-widget_type=\"jet-listing-grid.default\">\n\t\t\t\t\t<div class=\"jet-listing-grid jet-listing\"><div class=\"jet-listing-grid__items grid-col-desk-1 grid-col-tablet-1 grid-col-mobile-1 jet-listing-grid--4228 grid-collapse-gap\" data-queried-id=\"5990|WP_Post\" data-nav=\"{&quot;enabled&quot;:false,&quot;type&quot;:null,&quot;more_el&quot;:null,&quot;query&quot;:[],&quot;widget_settings&quot;:{&quot;lisitng_id&quot;:4228,&quot;posts_num&quot;:6,&quot;columns&quot;:1,&quot;columns_tablet&quot;:1,&quot;columns_mobile&quot;:1,&quot;column_min_width&quot;:240,&quot;column_min_width_tablet&quot;:240,&quot;column_min_width_mobile&quot;:240,&quot;inline_columns_css&quot;:false,&quot;is_archive_template&quot;:&quot;&quot;,&quot;post_status&quot;:[&quot;publish&quot;],&quot;use_random_posts_num&quot;:&quot;&quot;,&quot;max_posts_num&quot;:9,&quot;not_found_message&quot;:&quot;No data was found&quot;,&quot;is_masonry&quot;:false,&quot;equal_columns_height&quot;:&quot;&quot;,&quot;use_load_more&quot;:&quot;&quot;,&quot;load_more_id&quot;:&quot;&quot;,&quot;load_more_type&quot;:&quot;click&quot;,&quot;load_more_offset&quot;:null,&quot;use_custom_post_types&quot;:&quot;&quot;,&quot;custom_post_types&quot;:[],&quot;hide_widget_if&quot;:&quot;&quot;,&quot;carousel_enabled&quot;:&quot;&quot;,&quot;slides_to_scroll&quot;:&quot;1&quot;,&quot;arrows&quot;:&quot;true&quot;,&quot;arrow_icon&quot;:&quot;fa fa-angle-left&quot;,&quot;dots&quot;:&quot;&quot;,&quot;autoplay&quot;:&quot;true&quot;,&quot;pause_on_hover&quot;:&quot;true&quot;,&quot;autoplay_speed&quot;:5000,&quot;infinite&quot;:&quot;true&quot;,&quot;center_mode&quot;:&quot;&quot;,&quot;effect&quot;:&quot;slide&quot;,&quot;speed&quot;:500,&quot;inject_alternative_items&quot;:&quot;&quot;,&quot;injection_items&quot;:[],&quot;scroll_slider_enabled&quot;:&quot;&quot;,&quot;scroll_slider_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;,&quot;mobile&quot;],&quot;custom_query&quot;:&quot;yes&quot;,&quot;custom_query_id&quot;:&quot;29&quot;,&quot;_element_id&quot;:&quot;&quot;,&quot;collapse_first_last_gap&quot;:&quot;true&quot;,&quot;list_tag_selection&quot;:&quot;&quot;,&quot;list_items_wrapper_tag&quot;:&quot;div&quot;,&quot;list_item_tag&quot;:&quot;div&quot;,&quot;empty_items_wrapper_tag&quot;:&quot;div&quot;}}\" data-page=\"1\" data-pages=\"0\" data-listing-source=\"query\" data-listing-id=\"4228\" data-query-id=\"29\"><div class=\"jet-listing-grid__item jet-listing-dynamic-post-5903\" data-post-id=\"5903\"  >\t\t<div data-elementor-type=\"jet-listing-items\" data-elementor-id=\"6269\" class=\"elementor elementor-6269 elementor-4228 elementor-4228\" data-elementor-post-type=\"jet-engine\">\n\t\t\t\t<style>\n                .elementor-element-d3b27e5{\n                --padding-top: var(--webien-padding-top-none);\n                --padding-right: var(--webien-padding-right-none);\n                --padding-bottom: var(--webien-padding-bottom-none);\n                --padding-left: var(--webien-padding-left-none);\n                }\n            <\/style><a class=\"webien-container-padding-none elementor-element elementor-element-d3b27e5 haus-listing-item e-flex e-con-boxed e-con e-parent\" data-id=\"d3b27e5\" data-element_type=\"container\" data-e-type=\"container\" href=\"https:\/\/oncopeptides.com\/sv\/om-oss\/corporate-governance\/kommitteer\/valberedning-2025\/\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-6ce8cb5 elementor-widget elementor-widget-heading\" data-id=\"6ce8cb5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<span class=\"elementor-heading-title elementor-size-default\">Valberedning 2025<\/span>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ddf5b14 haus-icon elementor-view-default elementor-widget elementor-widget-icon\" data-id=\"ddf5b14\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"icon.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-icon-wrapper\">\n\t\t\t<div class=\"elementor-icon\">\n\t\t\t<i aria-hidden=\"true\" class=\"onco onco-Arrow-Onco\"><\/i>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t<\/div><div class=\"jet-listing-grid__item jet-listing-dynamic-post-5902\" data-post-id=\"5902\"  >\t\t<div data-elementor-type=\"jet-listing-items\" data-elementor-id=\"6269\" class=\"elementor elementor-6269 elementor-4228 elementor-4228\" data-elementor-post-type=\"jet-engine\">\n\t\t\t\t<style>\n                .elementor-element-d3b27e5{\n                --padding-top: var(--webien-padding-top-none);\n                --padding-right: var(--webien-padding-right-none);\n                --padding-bottom: var(--webien-padding-bottom-none);\n                --padding-left: var(--webien-padding-left-none);\n                }\n            <\/style><a class=\"webien-container-padding-none elementor-element elementor-element-d3b27e5 haus-listing-item e-flex e-con-boxed e-con e-parent\" data-id=\"d3b27e5\" data-element_type=\"container\" data-e-type=\"container\" href=\"https:\/\/oncopeptides.com\/sv\/om-oss\/corporate-governance\/kommitteer\/valberedning-2024\/\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-6ce8cb5 elementor-widget elementor-widget-heading\" data-id=\"6ce8cb5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<span class=\"elementor-heading-title elementor-size-default\">Valberedning 2024<\/span>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ddf5b14 haus-icon elementor-view-default elementor-widget elementor-widget-icon\" data-id=\"ddf5b14\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"icon.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-icon-wrapper\">\n\t\t\t<div class=\"elementor-icon\">\n\t\t\t<i aria-hidden=\"true\" class=\"onco onco-Arrow-Onco\"><\/i>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t<\/div><div class=\"jet-listing-grid__item jet-listing-dynamic-post-5892\" data-post-id=\"5892\"  >\t\t<div data-elementor-type=\"jet-listing-items\" data-elementor-id=\"6269\" class=\"elementor elementor-6269 elementor-4228 elementor-4228\" data-elementor-post-type=\"jet-engine\">\n\t\t\t\t<style>\n                .elementor-element-d3b27e5{\n                --padding-top: var(--webien-padding-top-none);\n                --padding-right: var(--webien-padding-right-none);\n                --padding-bottom: var(--webien-padding-bottom-none);\n                --padding-left: var(--webien-padding-left-none);\n                }\n            <\/style><a class=\"webien-container-padding-none elementor-element elementor-element-d3b27e5 haus-listing-item e-flex e-con-boxed e-con e-parent\" data-id=\"d3b27e5\" data-element_type=\"container\" data-e-type=\"container\" href=\"https:\/\/oncopeptides.com\/sv\/om-oss\/corporate-governance\/kommitteer\/valberedning-2023\/\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-6ce8cb5 elementor-widget elementor-widget-heading\" data-id=\"6ce8cb5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<span class=\"elementor-heading-title elementor-size-default\">Valberedning 2023<\/span>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ddf5b14 haus-icon elementor-view-default elementor-widget elementor-widget-icon\" data-id=\"ddf5b14\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"icon.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-icon-wrapper\">\n\t\t\t<div class=\"elementor-icon\">\n\t\t\t<i aria-hidden=\"true\" class=\"onco onco-Arrow-Onco\"><\/i>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t<\/div><div class=\"jet-listing-grid__item jet-listing-dynamic-post-5946\" data-post-id=\"5946\"  >\t\t<div data-elementor-type=\"jet-listing-items\" data-elementor-id=\"6269\" class=\"elementor elementor-6269 elementor-4228 elementor-4228\" data-elementor-post-type=\"jet-engine\">\n\t\t\t\t<style>\n                .elementor-element-d3b27e5{\n                --padding-top: var(--webien-padding-top-none);\n                --padding-right: var(--webien-padding-right-none);\n                --padding-bottom: var(--webien-padding-bottom-none);\n                --padding-left: var(--webien-padding-left-none);\n                }\n            <\/style><a class=\"webien-container-padding-none elementor-element elementor-element-d3b27e5 haus-listing-item e-flex e-con-boxed e-con e-parent\" data-id=\"d3b27e5\" data-element_type=\"container\" data-e-type=\"container\" href=\"https:\/\/oncopeptides.com\/sv\/om-oss\/corporate-governance\/kommitteer\/valberedning-2022\/\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-6ce8cb5 elementor-widget elementor-widget-heading\" data-id=\"6ce8cb5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<span class=\"elementor-heading-title elementor-size-default\">Valberedning 2022<\/span>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ddf5b14 haus-icon elementor-view-default elementor-widget elementor-widget-icon\" data-id=\"ddf5b14\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"icon.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-icon-wrapper\">\n\t\t\t<div class=\"elementor-icon\">\n\t\t\t<i aria-hidden=\"true\" class=\"onco onco-Arrow-Onco\"><\/i>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t<\/div><div class=\"jet-listing-grid__item jet-listing-dynamic-post-5909\" data-post-id=\"5909\"  >\t\t<div data-elementor-type=\"jet-listing-items\" data-elementor-id=\"6269\" class=\"elementor elementor-6269 elementor-4228 elementor-4228\" data-elementor-post-type=\"jet-engine\">\n\t\t\t\t<style>\n                .elementor-element-d3b27e5{\n                --padding-top: var(--webien-padding-top-none);\n                --padding-right: var(--webien-padding-right-none);\n                --padding-bottom: var(--webien-padding-bottom-none);\n                --padding-left: var(--webien-padding-left-none);\n                }\n            <\/style><a class=\"webien-container-padding-none elementor-element elementor-element-d3b27e5 haus-listing-item e-flex e-con-boxed e-con e-parent\" data-id=\"d3b27e5\" data-element_type=\"container\" data-e-type=\"container\" href=\"https:\/\/oncopeptides.com\/sv\/om-oss\/corporate-governance\/kommitteer\/valberedning-2021\/\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-6ce8cb5 elementor-widget elementor-widget-heading\" data-id=\"6ce8cb5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<span class=\"elementor-heading-title elementor-size-default\">Valberedning 2021<\/span>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ddf5b14 haus-icon elementor-view-default elementor-widget elementor-widget-icon\" data-id=\"ddf5b14\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"icon.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-icon-wrapper\">\n\t\t\t<div class=\"elementor-icon\">\n\t\t\t<i aria-hidden=\"true\" class=\"onco onco-Arrow-Onco\"><\/i>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t<\/div><div class=\"jet-listing-grid__item jet-listing-dynamic-post-6010\" data-post-id=\"6010\"  >\t\t<div data-elementor-type=\"jet-listing-items\" data-elementor-id=\"6269\" class=\"elementor elementor-6269 elementor-4228 elementor-4228\" data-elementor-post-type=\"jet-engine\">\n\t\t\t\t<style>\n                .elementor-element-d3b27e5{\n                --padding-top: var(--webien-padding-top-none);\n                --padding-right: var(--webien-padding-right-none);\n                --padding-bottom: var(--webien-padding-bottom-none);\n                --padding-left: var(--webien-padding-left-none);\n                }\n            <\/style><a class=\"webien-container-padding-none elementor-element elementor-element-d3b27e5 haus-listing-item e-flex e-con-boxed e-con e-parent\" data-id=\"d3b27e5\" data-element_type=\"container\" data-e-type=\"container\" href=\"https:\/\/oncopeptides.com\/sv\/om-oss\/corporate-governance\/kommitteer\/valberedning-2020\/\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-6ce8cb5 elementor-widget elementor-widget-heading\" data-id=\"6ce8cb5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<span class=\"elementor-heading-title elementor-size-default\">Valberedning 2020<\/span>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ddf5b14 haus-icon elementor-view-default elementor-widget elementor-widget-icon\" data-id=\"ddf5b14\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"icon.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-icon-wrapper\">\n\t\t\t<div class=\"elementor-icon\">\n\t\t\t<i aria-hidden=\"true\" class=\"onco onco-Arrow-Onco\"><\/i>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t<\/div><div class=\"jet-listing-grid__item jet-listing-dynamic-post-6017\" data-post-id=\"6017\"  >\t\t<div data-elementor-type=\"jet-listing-items\" data-elementor-id=\"6269\" class=\"elementor elementor-6269 elementor-4228 elementor-4228\" data-elementor-post-type=\"jet-engine\">\n\t\t\t\t<style>\n                .elementor-element-d3b27e5{\n                --padding-top: var(--webien-padding-top-none);\n                --padding-right: var(--webien-padding-right-none);\n                --padding-bottom: var(--webien-padding-bottom-none);\n                --padding-left: var(--webien-padding-left-none);\n                }\n            <\/style><a class=\"webien-container-padding-none elementor-element elementor-element-d3b27e5 haus-listing-item e-flex e-con-boxed e-con e-parent\" data-id=\"d3b27e5\" data-element_type=\"container\" data-e-type=\"container\" href=\"https:\/\/oncopeptides.com\/sv\/om-oss\/corporate-governance\/kommitteer\/valberedning-2019\/\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-6ce8cb5 elementor-widget elementor-widget-heading\" data-id=\"6ce8cb5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<span class=\"elementor-heading-title elementor-size-default\">Valberedning 2019<\/span>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ddf5b14 haus-icon elementor-view-default elementor-widget elementor-widget-icon\" data-id=\"ddf5b14\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"icon.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-icon-wrapper\">\n\t\t\t<div class=\"elementor-icon\">\n\t\t\t<i aria-hidden=\"true\" class=\"onco onco-Arrow-Onco\"><\/i>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t<\/div><div class=\"jet-listing-grid__item jet-listing-dynamic-post-5961\" data-post-id=\"5961\"  >\t\t<div data-elementor-type=\"jet-listing-items\" data-elementor-id=\"6269\" class=\"elementor elementor-6269 elementor-4228 elementor-4228\" data-elementor-post-type=\"jet-engine\">\n\t\t\t\t<style>\n                .elementor-element-d3b27e5{\n                --padding-top: var(--webien-padding-top-none);\n                --padding-right: var(--webien-padding-right-none);\n                --padding-bottom: var(--webien-padding-bottom-none);\n                --padding-left: var(--webien-padding-left-none);\n                }\n            <\/style><a class=\"webien-container-padding-none elementor-element elementor-element-d3b27e5 haus-listing-item e-flex e-con-boxed e-con e-parent\" data-id=\"d3b27e5\" data-element_type=\"container\" data-e-type=\"container\" href=\"https:\/\/oncopeptides.com\/sv\/om-oss\/corporate-governance\/kommitteer\/valberedning-2018\/\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-6ce8cb5 elementor-widget elementor-widget-heading\" data-id=\"6ce8cb5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<span class=\"elementor-heading-title elementor-size-default\">Valberedning 2018<\/span>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ddf5b14 haus-icon elementor-view-default elementor-widget elementor-widget-icon\" data-id=\"ddf5b14\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"icon.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-icon-wrapper\">\n\t\t\t<div class=\"elementor-icon\">\n\t\t\t<i aria-hidden=\"true\" class=\"onco onco-Arrow-Onco\"><\/i>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t<\/div><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"featured_media":0,"parent":4866,"template":"","meta":{"_acf_changed":false},"protected-content":[],"class_list":["post-5990","about-us","type-about-us","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/about-us\/5990","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/about-us"}],"about":[{"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/types\/about-us"}],"version-history":[{"count":8,"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/about-us\/5990\/revisions"}],"predecessor-version":[{"id":6526,"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/about-us\/5990\/revisions\/6526"}],"up":[{"embeddable":true,"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/about-us\/4866"}],"wp:attachment":[{"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/media?parent=5990"}],"wp:term":[{"taxonomy":"protected-content","embeddable":true,"href":"https:\/\/oncopeptides.com\/sv\/wp-json\/wp\/v2\/protected-content?post=5990"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}